President Donald Trump listens as Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci speaks during a coronavirus task force briefing at the White House, Friday, April 10, 2020, in Washington.

President Donald Trump listens as Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci speaks during a coronavirus task force briefing at the White House, Friday, April 10, 2020, in Washington. AP Photo/Evan Vucci

Trump Doesn't Know How to Safely Reopen the Country. Here Are 3 Ways to Do It

The president isn't talking about America's need to vastly expand testing and tracking — and the tradeoffs that might require.

Donald Trump made it clearer than ever Thursday evening that he doesn’t understand the crucial role that widespread coronavirus testing plays in getting America back to work again safely.

So while he talks a lot about reopening the country “very, very soon,” what he’s actually showing the world, every night, is that he has no idea what it will take to do that.

The overwhelming consensus among public-health experts is that it won’t be safe for Americans to resume anything like their normal lives until the country has the ability to test magnitudes more people than it does now. Social distancing appears to be reducing the uncontrolled spread of the virus, but if we can’t figure out who still has the virus, and keep them away from healthy people, then when we emerge from our homes, we’ll just start the cycle over.

What’s required, first and foremost, is massive testing — not only vastly more diagnostic testing than we’re doing now, but also what’s called “surveillance” testing, so that public-health officials can determine what communities are safe, and can identify outbreaks when they are still small and isolate the people who are infected.

President Obama weighed in on Thursday. He gets it:

A former Obama adviser put it a bit less delicately:

Indeed, there is no sign that Trump – preoccupied as he is with a fantasy narrative in which he and his administration have done everything perfectly — has a clue that testing needs to be ramped up.

CNN’s Jim Acosta asked exactly the right question at Thursday’s news conference.

Acosta: Mr. President, how could the administration discuss the possibility of reopening the country when the administration does not have an adequate nationwide testing system for this virus? Don’t you need a nationwide testing system for the virus before you reopen?

Trump said no.

Before you read Trump’s entire reply, you need to know a few things, to help you understand how meaningless it was:

  1. We don’t have the best testing system in the world. Per capita, we are badly trailing Germany, Italy, Australia, Canada, South Korea, and other several other countries.
  2. Every state in the nation has reported cases of the coronavirus.
  3. There is nothing “exponential” about the current increase in testing; it’s actually up about 30 percent over a week ago.
  4. Acosta wasn’t talking about testing every American, that’s a straw-man argument. He was talking about the kind of testing that would give public-health officials – and the public – a better sense of where the virus is and isn’t.

Now here’s what Trump said:

Trump: No. We have a great testing system — right now, the best testing system in the world. But there are certain sections –

Acosta: But people can’t get the test right now —

Trump: — there are certain sections in the country that are in phenomenal shape already. Other sections are coming online [sic]. Other sections are going down. And we, in addition to that, are giving out millions of tests and every day we’re doing it exponentially, we’re picking up, and what we’ll be doing in the very near future is going to certain areas of our country and do massive testing. It’s not necessary, but it would be a good thing to have.

Acosta: Don’t you have need, though, Mr. President, to make sure people are safe going back to work?  You don’t want to send people back to the workplace —

Trump: We want to have it. And we’re going to see if we have it. Do you need it? No. Is it a nice thing to do? Yes. We’re talking 325 million people. And that’s not going to happen, as you can imagine. It would never happen with anyone else, either.

Trump’s mention of “massive testing,” but only in “certain areas of our country,” was confusing at best, nonsensical at worst.

At Wednesday’s news conference, Trump was asked another good question: “So what specifically has to happen for you to feel that it is safe to reopen the country?  And what is your plan to do that?”

His answer was purely “aspirational” — as he now calls his earlier, Easter Sunday deadline for reopening:

Trump: Well, I think we can say that we have to be on that down side of that slope and heading to a very strong direction that this thing is gone.  We could do it in phases.  We can go to some areas, which you know.  Some areas are much less affected than others.

But it would be nice to be able to open with a big bang and open up our country — or certainly most of our country.  And I think we’re going to do that soon.  If you look at what’s happening, I would say we’re ahead of schedule.

Now, you hate to say it too loudly because, all of the sudden, things don’t happen.  But I think we will be sooner rather than later.  But we’ll be sitting down with the professionals.  We’ll be sitting down with many different people and making a determination.  And those meetings will start taking place fairly soon.

Asked about plans for “monitoring and testing,” Trump lied about the current level of testing and almost certainly made up a story about how “other countries” are now “calling us” for advice.

The roadmaps

Public-health experts are widely agreed on what needs to happen next, starting with a huge increase in testing, but also including a massive nationwide program of contact-tracing to find who may have been infected by the people who tested positive, and some sort of way of isolating the infected.

Each of those measures involve controversial tradeoffs, and complex federal oversight and support.

That’s what ought to be preoccupying Trump.

Specifically, scientists I trust have directed me to three policy roadmaps that provide exactly what the Trump administration is failing to provide: a detailed, point-by-point plan for how to reopen the country and end the crisis safely. They are also nearly identical in their broad strokes.

They are:

Reporters should hold Trump accountable to these roadmaps: Does he disagree with any of their conclusions or proposals? What if anything is he doing about them?

All three emphasize the danger of not having a serious, credible plan. As the CAP report states:

Without a coherent, evidence-based plan in place—a path forward, clear benchmarks, and an end in sight—the public and government officials may grow weary of physical distancing prematurely. The result would be repeated waves of exponential transmission followed by lockdowns, wreaking havoc on the economy and peoples’ lives. It will be far more devastating to our economy—and to public health—to experience waves and waves of virus response rather than properly return to normal when it is truly safe. Americans are willing to make sacrifices and do their part to break transmission, but they need to have faith that there is a plan in place that will work.

The next step, as the AEI report explains, is:

To move from community-wide interventions that focus on large populations to case-based interventions that target and isolate individual people who are infected.

That’s where widespread testing becomes essential. But, as the Duke report states:

Not one of the 50 U.S. states currently has surveillance capabilities sufficient to enable case-based interventions at the necessary scale. While these capacities are being scaled up in some places around the country, getting them to a level adequate to mitigate the risk of future outbreaks and epidemics will require a substantial expansion of our public health infrastructure and case-based management capabilities. With Federal support, surveillance mechanisms can be increased or implemented and better integrated with testing by providers.

None of this can happen just by flicking a switch, however. From the Duke report:

A reasonable first approach is to support rapid pilot program in some regions of the country that are already supporting existing surveillance capabilities. For example, Massachusetts recently announced a new program to hire and train 1,000 people to support contact tracing. Successful early models and best practices would provide the basis for CDC’s guidance to expand these capabilities throughout the country.

Finding a balance between the personal and technological approaches to contact-tracing is essential, and presents a rare area of disagreement.

The CAP report, for instance, urges an approach like South Korea and Singapore, using mobile phones to notify individuals if they have been in close proximity to an individual who has tested positive – but with data hosted by a trusted, nonprofit organization, “not private technology companies or the federal government.”

The Duke report, by contrast, concludes that a reliance on phones raises “serious privacy, security, and logistical concerns,” and instead recommends a substantial investment in strengthening the state and local public health workforce and a system for timely data-sharing.

The experts are agreed that affected individual should be isolated, often outside of their houses. The AEI reports says that “Comfortable, free facilities should be provided for cases and their contacts who prefer local isolation, quarantine, and treatment away from home.

Is anyone at the White House paying attention?

Only the U.S. government can set up the necessary testing network. Only the CDC can lead an effective contact-tracing program.

And ideally, the White House could lead a constructive national debate about the appropriate role of cell phone data in contact tracing and the right approach to isolating the sick.

Despite Trump’s belligerent ignorance, there are some signs that Vice President Pence and other members of the White House task force are at least a bit more aware of the variables involved — but how much isn’t clear.

Pence, after Trump left the room on Thursday, talked in very general terms about what needs to happen before places reopen. “First would be that we are at the end of the coronavirus for most major communities,” he said. And he said that “as we move into this summer and move into the fall, we’ll have the testing we need” to do both diagnostic and surveillance testing.

But he also said reopening depends on having “therapeutics for Americans to take medicines if they contract the disease” – which, unless you believe Trump’s snake-oil pitches for hydrochloroquine, isn’t necessarily anytime soon.

On CNN, the mostly invisible CDC director, Robert Redfield, offered a little more insight on Thursday evening, acknowledging the need for contract tracing and “using the data that we have from surveillance to understand the most important places for us to re-open.”

According to Politico, Anthony Fauci, the nation’s top infectious diseases expert, told lawmakers earlier this week “that administration officials are developing a framework for getting back to ‘normality’ and that he expects the White House to issue more guidance about eventually reopening society in the coming days.”

On Wednesday, Brett P. Giroir, the assistant secretary for health at the Department of Health and Human Services, discussed movement toward antibody testing. “This allows for surveillance screening… to understand is 1 percent, 5 percent, 30 percent of Americans have been infected.  But it also allows us to have very widespread — tens and tens of millions of people screened with a finger prick on the spot.”

He predicted that “if things work out the way we believe they will, we will have millions on the market by May — in a sophisticated way, in a prospective way — that we get the surveillance we need.  We can test people to see if they’ve been exposed, immune, and go back to work.  And a combination of that kind of test with the current kind of tests we have now is how America opens back up again.”

Meanwhile, Trump continues to be obsessed with his TV ratings, not testing. He continues to insist, vaguely, that everything will be better soon.

Emanuel, the lead author of the CAP report, recently told Deadline:

Everyone knows that the President knows nothing, and is just doing what he hopes, rather than what is realistic. What they want is what’s realistic. It’s, ‘Tell me what the plan is over that time.’…

I think I have a plan. There are other people who have slightly different plans, but we have to have a concerted discussion going forward.

The media’s role here is essential. Every time Trump says things are “headed in the right direction,” reporters should be demanding answers to specific questions about the plan forward – and should make it clear to the public that he has no serious, concrete, plausible, or credible plan at all.

Reporters need to expose his ignorance, rather than continue to indulge him — like the Washington Post’s Matt Zapotosky, Josh Dawsey, Jose A. Del Real and William Wan did Thursday night, in their story headlined “Trump administration pushing to reopen much of the U.S. next month”.

Read all the way down and you learn that he can’t do it (only the governors can); that health experts say it would be it would be completely crazy; and that no one in Trump’s inner circle can answer the simplest questions about how this could possibly be safe.

But Trump – and the zealots he listens to inside and outside the White House – got the headline they wanted, nonetheless.

This commentary was originally posted at Presswatchers.org. Used with permission.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.